{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:59:26Z","timestamp":1788609566076,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jtos.2013.02.003","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T06:45:26Z","timestamp":1373352326000},"page":"259-266","source":"Crossref","is-referenced-by-count":42,"title":["Current Medical Treatment of Ocular Mucous Membrane Pemphigoid"],"prefix":"10.1016","volume":"11","author":[{"given":"Bianka","family":"Sobolewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Deuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Zierhut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2013.02.003_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00130832-200410000-00017","article-title":"Ocular cicatricial pemphigoid rewiev","volume":"4","author":"Foster","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jtos.2013.02.003_bib2","first-page":"191","article-title":"Mucous membrane pemphigoid: clinical aspects, immunopathological features and therapy","volume":"17","author":"Bruch-Gerharz","year":"2007","journal-title":"Eur J Deramtol"},{"key":"10.1016\/j.jtos.2013.02.003_bib3","first-page":"527","article-title":"Cicatricial pemphigoid","volume":"84","author":"Foster","year":"1986","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.jtos.2013.02.003_bib4","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/eye.2011.175","article-title":"Evaluation of early and late presentation of patients with ocular mucous membrane pemphigoid to two major tertiary referral hospitals in the United Kingdom","volume":"25","author":"Williams","year":"2011","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2013.02.003_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ophtha.2007.04.027","article-title":"Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes","volume":"115","author":"Saw","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2013.02.003_bib6","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/archderm.1942.01500180020004","article-title":"Pemphigus: a historical study","volume":"46","author":"Lever","year":"1942","journal-title":"Arch Dermatol Syph"},{"key":"10.1016\/j.jtos.2013.02.003_bib7","first-page":"109","article-title":"Ocular pemphigus: a clinical presentation","volume":"62","author":"Bedell","year":"1964","journal-title":"Trans Am Ophthalmol\u00a0Soc"},{"key":"10.1016\/j.jtos.2013.02.003_bib8","series-title":"Cornea: Fundamentals, Diagnosis, and Management.","first-page":"591","article-title":"Cicatricial pemphigoid","volume":"Vol. 1","author":"Foster","year":"2011"},{"key":"10.1016\/j.jtos.2013.02.003_bib9","doi-asserted-by":"crossref","first-page":"11579","DOI":"10.1073\/pnas.88.24.11579","article-title":"Association of DQw7 (DQ\u03b21*0301) with ocular cicatricial pemphigoid","volume":"88","author":"Ahmed","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtos.2013.02.003_bib10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1076\/0271-3683(200008)2121-VFT646","article-title":"Influence of intravenous immuglobulin therapy on serum levels of anti-\u03b24 antibodies in ocular cicatricial pemphigoid","volume":"21","author":"Letko","year":"2000","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2013.02.003_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0161-6420(81)35069-6","article-title":"Ocular cicatricial pemphigoid","volume":"88","author":"Mondino","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2013.02.003_bib12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00003226-199209000-00015","article-title":"Improved detection of disease progression in ocular cicatricial pemphigoid","volume":"11","author":"Tauber","year":"1992","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2013.02.003_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archopht.122.2.179","article-title":"A\u00a0new method for measuring progression in patients with ocular cicatricial pemphigoid","volume":"122","author":"Rowsey","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2013.02.003_bib14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00417-011-1853-z","article-title":"Ocular and oral grading of mucous membrane pemphigoid","volume":"250","author":"Reeves","year":"2012","journal-title":"Graefes Arch Clin Eyp Opthalmol"},{"key":"10.1016\/j.jtos.2013.02.003_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ophtha.2003.03.001","article-title":"Mucous membrane pemphigoid and pseudopemphigoid","volume":"111","author":"Thorne","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2013.02.003_bib16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1684\/ejd.2009.0740","article-title":"Immune diagnosis of pure ocular mucous membrane pemphigoid: indirect immunofluorescence versus immunoblot","volume":"19","author":"Jonkman","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jtos.2013.02.003_bib17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jtos.2013.02.003_bib18","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.ophtha.2005.01.039","article-title":"Evaluation of mucous membrane pemphigoid with ocular involvement in young patients","volume":"112","author":"Rauz","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2013.02.003_bib19","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0161-6420(01)00657-1","article-title":"Treatment of ocular cicatricial pemphigoid with sulfasalazine","volume":"108","author":"Doan","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2013.02.003_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0161-6420(01)00863-6","article-title":"The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid","volume":"109","author":"Miserocchi","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2013.02.003_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ajo.2009.09.026","article-title":"Mycophenolate mofetil for ocular inflammation","volume":"149","author":"Daniel","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2013.02.003_bib22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/09273948.2011.624288","article-title":"Long-term results of therapy with mycophenolate mofetil in ocular mucous membrane pemphigoid","volume":"19","author":"Doycheva","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jtos.2013.02.003_bib23","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.preteyeres.2004.05.005","article-title":"Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment","volume":"23","author":"Ahmed","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jtos.2013.02.003_bib24","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ophtha.2003.07.010","article-title":"Methotrexate therapy for ocular cicatricial pemphigoid","volume":"111","author":"McCluskey","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2013.02.003_bib25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.53.7.434","article-title":"Methotrexate-related pulmonary comlications in patients with rheumatoid arthritis","volume":"53","author":"Barrera","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtos.2013.02.003_bib26","first-page":"1017","article-title":"Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature","volume":"27","author":"Visser","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jtos.2013.02.003_bib27","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajo.2009.05.008","article-title":"Azathioprine for ocular inflammatory disease","volume":"148","author":"Pasadhika","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2013.02.003_bib28","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.ophtha.2008.08.002","article-title":"Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy","volume":"115","author":"Thorne","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2013.02.003_bib29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archderm.139.8.1051","article-title":"Consensus statement on the use of intravenous immunoglobulin therapy in the treatment autoimmune mucocutaneous blistering diseases","volume":"139","author":"Ahmed","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jtos.2013.02.003_bib30","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.ophtha.2003.11.012","article-title":"Intravenous immunoglobulin therapy in patients with ocular cicatricial pemphigoid","volume":"111","author":"Sami","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2013.02.003_bib31","first-page":"1457","article-title":"Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients","volume":"142","author":"Canizares","year":"2006","journal-title":"Arch Dermaol"},{"key":"10.1016\/j.jtos.2013.02.003_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2340\/00015555-0132","article-title":"Treatment of ocular cicatricial pemphigoid with the tumor necrosis factor alfa antagonist etanercept","volume":"87","author":"Prey","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jtos.2013.02.003_bib33","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archderm.142.10.1268","article-title":"Successful treatment of mucous membrane pemphigoid with infliximab","volume":"142","author":"Heffernan","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jtos.2013.02.003_bib34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.5301\/EJO.2011.6294","article-title":"Pentoxifylline (anti-tumor necrosis factor drug): effective adjuvant therapy in\u00a0the control of ocular cicatricial pemphigoid","volume":"21","author":"El Darouti","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jtos.2013.02.003_bib35","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ophtha.2009.09.049","article-title":"Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid","volume":"117","author":"Foster","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2013.02.003_bib36","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/archdermatol.2011.54","article-title":"Rituximab for patients with refractory mucous membrane pemphigoid","volume":"147","author":"Le Roux-Villet","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jtos.2013.02.003_bib37","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1186\/ar3337","article-title":"Safety and clinical outcome of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)","volume":"13","author":"Tony","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jtos.2013.02.003_bib38","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1610-0387.2007.06602.x","article-title":"Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases","volume":"6","author":"Hertl","year":"2008","journal-title":"JDDG"},{"key":"10.1016\/j.jtos.2013.02.003_bib39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ajpath.2010.11.013","article-title":"Profibrotic phenotype of conjunctival fibroblasts from mucous membrane pemphigoid","volume":"178","author":"Saw","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtos.2013.02.003_bib40","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1167\/iovs.08-3345","article-title":"Tumor necrosis factor-alfa in ocular mucous membrane pemphigoid and its effect on conjunctival fibroblasts","volume":"50","author":"Saw","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012413000803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012413000803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T03:40:57Z","timestamp":1596080457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012413000803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1542012413000803"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2013.02.003","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}